• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amdocs Limited Reports Second Quarter Fiscal 2023 Results

    5/10/23 4:01:00 PM ET
    $DOX
    EDP Services
    Technology
    Get the next $DOX alert in real time by email

    Record Quarterly Revenue of $1.22 Billion, Above Midpoint of Guidance and up 6.8% YoY as Reported and 8.2% YoY in Constant Currency(2)
    Reiterates Fiscal 2023 Revenue Growth Outlook while Tightening Expected Range to 6%-8% as Reported and 7%-9% Constant Currency(2)
    Reiterates Fiscal 2023 Earnings per Share Growth Targets
    Reiterates Fiscal 2023 Free Cash Flow(1) Outlook of $700 Million

    Second Quarter Fiscal 2023 Highlights

    (All comparisons are against the prior year)

    • Record revenue of $1,223 million, up 6.8% as reported and up 8.2% in constant currency(2); revenue was above the midpoint of $1,200-$1,240 million guidance range
    • Record revenue of $829 million in North America, up 7.4%, and record revenue of $172 million in Europe, up 16.6%
    • Record managed services revenue of $719 million, equivalent to approximately 59% of total revenue
    • GAAP diluted EPS of $1.23, above the midpoint of $1.18-$1.26 guidance range
    • Non-GAAP diluted EPS of $1.47, at the midpoint guidance range of $1.44-$1.50
    • GAAP operating income of $182 million; GAAP operating margin of 14.9%, up 220 basis points sequentially, primarily due to restructuring charges, and up 60 basis points as compared to last year's second fiscal quarter
    • Non-GAAP operating income of $218 million; non-GAAP operating margin of 17.8%, up 10 basis points sequentially and up 20 basis points as compared to last year's second fiscal quarter
    • Free cash flow of $259 million, comprised of cash flow from operations of $294 million, less $35 million in net capital expenditures and other(1); reiterates full year fiscal 2023 free cash outlook of $700 million
    • Repurchased $106 million of ordinary shares during the second fiscal quarter
    • Record twelve-month backlog of $4.11 billion, up 5.7% as compared to last year's second fiscal quarter
    • The Board of Directors of Amdocs approved a definitive agreement on May 10, 2023, to acquire the service assurance business of TEOCO for a consideration of approximately $90 million in cash, subject to closing conditions

    JERSEY CITY, NJ / ACCESSWIRE / May 10, 2023 / Amdocs Limited (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today reported operating results for the three months ended March 31, 2023.

    "I am pleased with our second fiscal quarter performance as we progressed our strategy to deliver the next-generation cloud-based products and software services that global communications service providers need to unlock the potential of 5G and broadband networks, data-driven intelligence, and improved consumer and B2B experience. Record revenue of $1.22 billion was up 8.2% from a year ago in constant currency(2), driven by our best-ever quarters in North America and Europe, and we saw continued sales momentum with many cloud-related wins in the quarter. New deals included key awards with T-Mobile in the US, two new logos in Eastern Europe, and a significant cloud-migration engagement with PLDT in the Philippines. On the strategic front, we expanded our Microsoft partnership to bring a new AI-powered Customer Engagement Platform, and we sharpened our focus on the growth potential of B2B with the launch of CES23, our most advanced Customer Experience Suite yet. Additionally, we signed a definitive agreement to acquire the service assurance business of TEOCO to enhance the execution of our network automation strategy," said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.

    "Demonstrating strong execution, we maintained a high rate of project deployments in Q2, which included major milestone achievements with many of the world's largest service providers. Driven by ongoing efficiency gains, profitability improved on a sequential and year ago basis and free cash flow generation was very strong on the back of healthy cash collections from customers. In managed services, we renewed several customer agreements which included an extended multiyear partnership with Globe in the Philippines and an expanded cloud-related engagement with a major Western European operator," said Tamar Rapaport-Dagim, chief financial officer & chief operating officer of Amdocs Management Limited.

    Sheffer concluded, "As said previously, Amdocs and our global customers are not immune to economic and industry cycles, and we continue to closely monitor the operating environment. As a key technology enabler, we believe Amdocs is positioned at the heart of a multi-year, technology-driven investment cycle centered around the major long-term trends of 5G, network automation, digital modernization, and cloud. Moreover, we believe Amdocs' role as a trusted partner is even more relevant during this period of rapidly shifting market dynamics as we work to help service providers improve consumer and B2B experience, accelerate cost reduction, and increase efficiency. Overall, considering our strong first half performance and the visibility provided by our unique business model, we expect to deliver constant currency(2) revenue growth within a tighter range of 7% to 9% in fiscal 2023, while maintaining improved profitability and robust earnings to cash conversion for the full year."

    Revenue

    (All comparisons are against the prior year period)


    In millions
    Three months ended
    March 31, 2023
    Actual Guidance
    Revenue $1,223 $1,200 - $1,240
    Revenue Growth, as reported
    6.8%
    Revenue Growth, constant currency (2)
    8.2%
    • Revenue for the second fiscal quarter of 2023 was at the midpoint of Amdocs' guidance, even after adjusting for a positive impact from foreign currency movements of approximately $3 million compared to our guidance assumptions
    • Revenue for the second fiscal quarter includes a positive impact from foreign currency movements of approximately $7 million relative to the first quarter of fiscal 2023

    Net Income and Earnings Per Share

    In thousands, expect per share data
    Three months ended
    March 31,
    2023 2022
    GAAP Measures
    Net Income
    $150,309 $158,497
    Net Income attributable to Amdocs Limited
    $149,603 $158,497
    Diluted earnings per share
    $1.23 $1.28
    Non-GAAP Measures
    Non-GAAP Net Income
    $179,298 $190,944
    Non-GAAP Net Income attributable to Amdocs Limited
    $178,592 $190,944
    Non-GAAP Diluted earnings per share
    $1.47 $1.54
    • Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition related liabilities measured at fair value, equity-based compensation expenses and other, net of related tax effects, in all the periods presented.

    For further details of the reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.

    Capital Allocation: Returning Cash to Shareholders

    • Quarterly Cash Dividend Program: On May 10, 2023, the Board approved the Company's next quarterly cash dividend payment of $0.435 per share and set June 30, 2023 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on July 28, 2023
    • Share Repurchase Activity: Repurchased $106 million of ordinary shares during the second quarter of fiscal 2023

    Twelve-month Backlog

    Twelve-month backlog was a record $4.11 billion at the end of the second quarter of fiscal 2023, up approximately 5.7% as compared to last year's second fiscal quarter. Twelve-month backlog includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities.

    Third Quarter Fiscal 2023 Outlook

    In millions, expect per share data
    Q3 - 2023
    Revenue
    $1,215-$1,255
    GAAP Diluted earnings per share
    $1.16-$1.26
    Non-GAAP Diluted earnings per share
    $1.45-$1.51
    • Third quarter revenue guidance assumes immaterial sequential impact from foreign currency fluctuations as compared to the second quarter of fiscal 2023
    • Third quarter non-GAAP diluted EPS guidance excludes equity-based compensation expense of approximately $0.15-$0.17 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.08 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects

    Full Year Fiscal 2023 Outlook


    FY 2023 - Year-over -Year growth
    Current guidance Previous guidance
    Revenue Growth, as reported
    6.0%-8.0% 5.0%-9.0%
    Revenue Growth, constant currency (2)
    7.0%-9.0% 6.0%-10.0%
    GAAP Diluted earnings per share
    3.0%-10.0% 3.0%-10.0%
    Non-GAAP Diluted earnings per share
    9.0%-13.0% 9.0%-13.0%

    FY 2023, in millions
    Current guidance Previous guidance
    Free Cash Flow (1) $700 $700
    • Full year fiscal 2023 revenue guidance incorporates an expected unfavorable impact from foreign currency fluctuations of approximately 1% year-over-year, consistent with previous expectation
    • Non-GAAP diluted earnings per share growth excludes equity-based compensation expense of approximately $0.58-$0.63 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.35 per share, restructuring charges of approximately $0.15 per share, changes in certain acquisitions related liabilities measured at fair value, and other, net of related tax effects
    • Non-GAAP effective tax rate is anticipated to be within a range of 13.0% to 17.0% for the full year fiscal 2023
    • Free cash flow(1) is comprised of cash flow from operations, less net capital expenditures and other

    The forward looking statements regarding our third fiscal quarter 2023 and full year fiscal 2023 guidance take into consideration the Company's current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from certain geopolitical events, the current inflationary environment, global or regional events, such as the COVID-19 pandemic and the prevailing level of macro-economic, business and operational uncertainty, which have created, and continues to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.

    Conference Call and Earnings Webcast Presentation Details

    Amdocs will host a conference call and earnings webcast presentation on May 10, 2023 at 5:00 p.m. Eastern Time to discuss the Company's second quarter of fiscal 2023 results.

    To participate in the call, please register here to receive the dial-in numbers and unique access PIN. The conference call and webcast will also be carried live on the Internet and may be accessed via the Amdocs website at https://investors.amdocs.com. Presentation slides will be available shortly before the webcast.

    Non-GAAP Financial Measures
    This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow and normalized free cash flow, revenue on a constant currency(2) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth. These other non-GAAP measures exclude the following items:

    • amortization of purchased intangible assets and other acquisition-related costs;
    • changes in certain acquisition-related liabilities measured at fair value;
    • restructuring and unusual charges or benefits (such as a gain from divestiture of OpenMarket);
    • equity-based compensation expense;
    • other; and
    • tax effects related to the above.

    Free cash flow equals cash generated by operating activities less net capital expenditures and other. Normalized free cash flow, a measure of our operating performance, is further adjusted to exclude net capital expenditures related to the new campus development, payments for non-recurring and unusual charges (such as capital gains tax in relation to the divestiture of OpenMarket), and payments of acquisition related liabilities. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures.

    Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow and normalized free cash flow, revenue on a constant currency(2) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

    For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, restructuring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

    Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

    Supporting Resources

    • Keep up with Amdocs news by visiting the Company's website
    • Subscribe to Amdocs' RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube

    About Amdocs

    Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers' innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and large enterprise customers. Our 31,000 employees around the globe are here to accelerate service providers' migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.58 billion in fiscal 2022.

    For more information, visit Amdocs at www.amdocs.com.

    This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macro-economic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other global or regional events such as the COVID-19 pandemic, as well as the current inflationary environment, and the effects of these conditions on the company's clients' businesses and levels of business activity, Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2022 filed on December 13, 2022 and our Form 6-K furnished for the first quarter of fiscal 2023 on February 13, 2023.

    Contact:
    Matthew Smith
    Head of Investor Relations
    Amdocs
    314-212-8328
    E-mail: [email protected]

    AMDOCS LIMITED
    Consolidated Statements of Income
    (In thousands, except per share data)

    Three months ended
    March 31,
    Six months ended
    March 31,
    2023 2022 2023 2022
    Revenue
    $1,223,304 $1,145,271 $2,409,024 $2,249,903
    Operating expenses:
    Cost of revenue
    795,485 741,257 1,552,334 1,457,975
    Research and development
    89,274 87,064 185,000 169,009
    Selling, general and administrative
    143,328 134,982 286,550 263,058
    Amortization of purchased intangible assets and other
    12,940 18,317 28,253 36,064
    Restructuring charges
    - - 24,536 -
    1,041,027 981,620 2,076,673 1,926,106
    Operating income
    182,277 163,651 332,351 323,797
    Interest and other expense, net
    (2,938) (8,619) (7,901) (11,181)
    Gain from sale of a business
    - - - 10,000
    Income before income taxes
    179,339 155,032 324,450 322,616
    Income tax expense (benefit)
    29,030 (3,465) 44,269 30,517
    Net income
    $150,309 $158,497 $280,181 $292,099
    Net income attributable to noncontrolling interests
    706 - 911 -
    Net income attributable to Amdocs Limited
    $149,603 $158,497 $279,270 $292,099
    Basic earnings per share attributable to Amdocs Limited
    $1.24 $1.29 $2.32 $2.36
    Diluted earnings per share attributable to Amdocs Limited
    $1.23 $1.28 $2.30 $2.34
    Cash dividends declared per ordinary share
    $0.435 $0.395 $0.830 $0.755
    Basic weighted average number of shares outstanding
    120,516 122,977 120,585 123,748
    Diluted weighted average number of shares outstanding
    121,359 123,821 121,430 124,571

    AMDOCS LIMITED
    Selected Financial Metrics
    (In thousands, except per share data)

    Three months ended
    March 31,
    Six months ended
    March 31,
    2023 2022 2023 2022
    Revenue
    $1,223,304 $1,145,271 $2,409,024 $2,249,903
    Non-GAAP operating income
    217,737 201,625 427,275 395,232
    Non-GAAP net income
    179,298 190,944 355,840 341,079
    Non-GAAP net income attributable to Amdocs Limited
    178,592 190,944 354,929 341,079
    Non-GAAP diluted earnings per share
    $1.47 $1.54 $2.92 $2.74
    Diluted weighted average number of shares outstanding
    121,359 123,821 121,430 124,571

    Free Cash Flows
    (In thousands)

    Three months ended
    March 31,
    Six months ended
    March 31,
    2023 2022 2023 2022
    Net Cash Provided by Operating Activities
    $294,476 $168,856 $377,702 $372,974
    Purchases of property and equipment, net (a)
    (35,119) (47,271) (68,822) (104,496)
    Free Cash Flow
    $259,357 $121,585 $308,880 $268,478

    Normalized Free Cash Flow (b) for the three and six months ended March 31, 2022: $159,758 and $345,437, respectively, excluding net capital expenditures related to the new campus development of $30,109 and $59,416, respectively, payment for acquisition related liability of $4,871 and $14,350, respectively, and tax payment on sale of business of $3,193.


    (a) The amounts under "Purchase of property and equipment, net" include proceeds from sale of property and equipment of $255 and $555 for the six months ended March 31, 2023 and 2022, respectively.
    (b) Since Q12023, the Normalized Free Cash Flow is no longer applicable.

    AMDOCS LIMITED
    Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
    (In thousands)

    Three Months Ended March 31, 2023
    GAAP Amortization of purchased intangible assets and other Equity based compensation expense Changes in certain acquisitions related liabilities measured at fair value Tax
    effect
    Non-GAAP
    Operating expenses:
    Cost of revenue
    $795,485 $- $(10,061) $(1,159) $- $784,265
    Research and development
    89,274 (1,703) 87,571
    Selling, general and administrative
    143,328 (9,597) 133,731
    Amortization of purchased intangible assets and other
    12,940 (12,940) -
    Total operating expenses
    1,041,027 (12,940) (21,361) (1,159) - 1,005,567
    Operating income
    182,277 12,940 21,361 1,159 - 217,737
    Interest and other expense, net
    (2,938) (2,938)
    Income taxes
    29,030 6,471 35,501
    Net income
    150,309 12,940 21,361 1,159 (6,471) 179,298
    Net income attributable to noncontrolling interests
    706 706
    Net income attributable to Amdocs Limited
    $149,603 $12,940 $21,361 $1,159 $(6,471) $178,592
    Three Months Ended March 31, 2022
    GAAP Amortization of purchased intangible assets and other Equity based compensation expense Changes in certain acquisitions related liabilities measured at fair value Other Tax
    effect
    Non-GAAP
    Operating expenses:
    Cost of revenue
    $741,257 $- $(8,070) $(1,820) $- $- $731,367
    Research and development
    87,064 (1,375) 85,689
    Selling, general and administrative
    134,982 (8,392) 126,590
    Amortization of purchased intangible assets and other
    18,317 (18,317) -
    Total operating expenses
    981,620 (18,317) (17,837) (1,820) - - 943,646
    Operating income
    163,651 18,317 17,837 1,820 - - 201,625
    Interest and other expense, net
    (8,619) 1,100 (7,519)
    Income tax (benefit) expense
    (3,465) 6,627 3,162
    Net income
    $158,497 $18,317 $17,837 $1,820 $1,100 $(6,627) $190,944

    AMDOCS LIMITED
    Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
    (In thousands)

    Six Months Ended March 31, 2023
    GAAP Amortization of purchased intangible assets and other Equity based compensation expense Changes in certain acquisitions related liabilities measured at fair value Restructuring charges Tax
    effect
    Non-GAAP
    Operating expenses:
    Cost of revenue
    $1,552,334 $- $(18,716) $(1,284) $- $- $1,532,334
    Research and development
    185,000 (3,187) 181,813
    Selling, general and administrative
    286,550 (18,948) 267,602
    Amortization of purchased intangible assets and other
    28,253 (28,253) -
    Restructuring charges
    24,536 (24,536) -
    Total operating expenses
    2,076,673 (28,253) (40,851) (1,284) (24,536) - 1,981,749
    Operating income
    332,351 28,253 40,851 1,284 24,536 - 427,275
    Interest and other expense, net
    (7,901) (7,901)
    Income taxes
    44,269 19,265 63,534
    Net income
    280,181 28,253 40,851 1,284 24,536 (19,265) 355,840
    Net income attributable to noncontrolling interests
    911 911
    Net income attributable to Amdocs Limited
    $279,270 $28,253 $40,851 $1,284 $24,536 $(19,265) $354,929
    Six Months Ended March 31, 2022
    GAAP Amortization of purchased intangible assets and other Equity based compensation expense Changes in certain acquisitions related liabilities measured at fair value Gain from sale of a business Other Tax
    effect
    Non-GAAP
    Operating expenses:
    Cost of revenue
    $1,457,975 $- $(15,217) $(793) $- $- $- $1,441,965
    Research and development
    169,009 (2,598) 166,411
    Selling, general and administrative
    263,058 (16,763) 246,295
    Amortization of purchased intangible assets and other
    36,064 (36,064) -
    Total operating expenses
    1,926,106 (36,064) (34,578) (793) - - - 1,854,671
    Operating income
    323,797 36,064 34,578 793 - - - 395,232
    Interest and other expense, net
    (11,181) (2,505) (13,686)
    Gain from sale of a business
    10,000 $(10,000) -
    Income tax (benefit) expense
    30,517 9,950 40,467
    Net income
    $292,099 $36,064 $34,578 $793 $(10,000) $(2,505) $(9,950) 341,079

    AMDOCS LIMITED
    Condensed Consolidated Balance Sheets
    (In thousands)

    As of
    March 31,
    2023
    September 30,
    2022
    ASSETS
    Current assets:
    Cash and cash equivalents
    $623,404 $573,377
    Short-term interest-bearing investments
    238,163 244,603
    Accounts receivable, net, including unbilled of $166,866 and $157,165, respectively
    991,486 946,777
    Prepaid expenses and other current assets
    251,883 238,390
    Total current assets
    2,104,936 2,003,147
    Property and equipment, net
    797,023 794,287
    Lease assets
    157,587 176,884
    Goodwill and other intangible assets, net
    2,798,295 2,841,137
    Other noncurrent assets
    606,329 574,938
    Total assets
    $6,464,170 $6,390,393
    LIABILITIES AND SHAREHOLDERS' EQUITY
    Current liabilities
    Accounts payable, accruals and other
    $934,907 $955,658
    Lease liabilities
    38,319 43,336
    Deferred revenue
    351,671 253,686
    Total current liabilities
    1,324,897 1,252,680
    Lease liabilities
    120,170 138,378
    Long-term debt, net of unamortized debt issuance costs
    645,404 645,117
    Other noncurrent liabilities
    744,138 793,940
    Total Amdocs Limited Shareholders' equity
    3,586,141 3,517,769
    Noncontrolling interests
    43,420 42,509
    Total equity
    3,629,561 3,560,278
    Total liabilities and equity
    $6,464,170 $6,390,393

    AMDOCS LIMITED
    Consolidated Statements of Cash Flows
    (In thousands)

    Six months ended
    March 31,
    2023 2022
    Cash Flow from Operating Activities:
    Net income
    $280,181 $292,099
    Reconciliation of net income to net cash provided by operating activities:
    Depreciation, amortization and impairment
    103,086 101,071
    Amortization of debt issuance cost
    287 279
    Equity-based compensation expense
    40,851 34,578
    Gain from sale of a business
    - (10,000)
    Deferred income taxes
    (27,357) (35,879)
    Loss from short-term interest-bearing investments
    1,625 1,333
    Net changes in operating assets and liabilities, net of amounts acquired:
    Accounts receivable, net
    (53,485) (140,863)
    Prepaid expenses and other current assets
    (20,416) 3,848
    Other noncurrent assets
    (245) 3,042
    Lease assets and liabilities, net
    (3,928) (67)
    Accounts payable, accrued expenses and accrued personnel
    (38,602) (22,006)
    Deferred revenue
    81,959 102,997
    Income taxes payable, net
    (11,245) 27,378
    Other noncurrent liabilities
    24,991 15,164
    Net cash provided by operating activities
    377,702 372,974
    Cash Flow from Investing Activities:
    Purchase of property and equipment, net (a)
    (68,822) (104,496)
    Proceeds from sale of short-term interest-bearing investments
    10,360 13,142
    Purchase of short-term interest-bearing investments
    - (34,275)
    Net cash paid for business acquisitions
    - (24,497)
    Net cash received from sale of a business
    - 10,000
    Other
    (2,593) (2,958)
    Net cash used in investing activities
    (61,055) (143,084)
    Cash Flow from Financing Activities:
    Repurchase of shares
    (205,637) (300,929)
    Proceeds from employee stock option exercises
    34,840 50,550
    Payments of dividends
    (95,370) (89,366)
    Payment of contingent consideration from a business acquisition
    (453) (6,153)
    Net cash used in financing activities
    (266,620) (345,898)
    Net increase (decrease) in cash and cash equivalents
    50,027 (116,008)
    Cash and cash equivalents at beginning of period
    573,377 709,064
    Cash and cash equivalents at end of period
    $623,404 $593,056

    AMDOCS LIMITED
    Supplementary Information
    (In millions)

    Three months ended
    March 31, December 31, September 30, June 30, March 31,
    2023 2022 2022 2022 2022
    North America
    $829.0 $812.7 $794.4 $788.0 $772.2
    Europe
    171.7 168.7 146.4 146.1 147.2
    Rest of the World
    222.6 204.3 225.7 226.2 225.9
    Total Revenue
    $1,223.3 $1,185.7 $1,166.5 $1,160.3 $1,145.3

    Three months ended
    March 31, December 31, September 30, June 30, March 31,
    2023 2022 2022 2022 2022
    Managed Services Revenue $718.9 $699.8 $714.6 $717.9 $663.4
    as of
    March 31, December 31, September 30, June 30, March 31,
    2023 2022 2022 2022 2022
    12-Month Backlog $4,110 $4,090 $3,970 $3,950 $3,890

    SOURCE: Amdocs Management Limited



    View source version on accesswire.com:
    https://www.accesswire.com/753944/Amdocs-Limited-Reports-Second-Quarter-Fiscal-2023-Results

    Get the next $DOX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOX

    DatePrice TargetRatingAnalyst
    10/2/2024$100.00Buy
    Stifel
    12/1/2023$105.00Buy
    Jefferies
    5/16/2023$100.00 → $115.00Equal Weight → Overweight
    Barclays
    12/14/2021$91.00 → $86.00Overweight → Neutral
    JP Morgan
    8/5/2021$84.00 → $99.00Outperform
    Oppenheimer
    More analyst ratings

    $DOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Stifel initiated coverage on Amdocs with a new price target

      Stifel initiated coverage of Amdocs with a rating of Buy and set a new price target of $100.00

      10/2/24 7:26:06 AM ET
      $DOX
      EDP Services
      Technology
    • Jefferies initiated coverage on Amdocs with a new price target

      Jefferies initiated coverage of Amdocs with a rating of Buy and set a new price target of $105.00

      12/1/23 7:28:05 AM ET
      $DOX
      EDP Services
      Technology
    • Amdocs upgraded by Barclays with a new price target

      Barclays upgraded Amdocs from Equal Weight to Overweight and set a new price target of $115.00 from $100.00 previously

      5/16/23 7:13:02 AM ET
      $DOX
      EDP Services
      Technology

    $DOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Amdocs Limited (Amendment)

      SC 13G/A - AMDOCS LTD (0001062579) (Subject)

      2/9/24 11:49:02 AM ET
      $DOX
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Amdocs Limited (Amendment)

      SC 13G/A - AMDOCS LTD (0001062579) (Subject)

      2/9/24 8:35:54 AM ET
      $DOX
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by Amdocs Limited (Amendment)

      SC 13G/A - AMDOCS LTD (0001062579) (Subject)

      2/9/23 8:23:46 AM ET
      $DOX
      EDP Services
      Technology

    $DOX
    SEC Filings

    See more
    • SEC Form 6-K filed by Amdocs Limited

      6-K - AMDOCS LTD (0001062579) (Filer)

      5/7/25 8:01:03 PM ET
      $DOX
      EDP Services
      Technology
    • SEC Form 6-K filed by Amdocs Limited

      6-K - AMDOCS LTD (0001062579) (Filer)

      2/18/25 4:09:59 PM ET
      $DOX
      EDP Services
      Technology
    • SEC Form 6-K filed by Amdocs Limited

      6-K - AMDOCS LTD (0001062579) (Filer)

      12/23/24 4:05:02 PM ET
      $DOX
      EDP Services
      Technology

    $DOX
    Leadership Updates

    Live Leadership Updates

    See more
    • Amdocs Awarded Two 2024 AWS Partner Awards

      Amdocs recognized as winner in two categories - Industry Partner of the Year - Telco (Global) and Industry Partner of the Year - Telco (North America), recognizing top AWS Partners who enable telco customers to drive innovationJERSEY CITY, NJ / ACCESSWIRE / December 3, 2024 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced it is a recipient of the 2024 Geography and Global AWS Partner Award, recognizing leaders around the globe that are playing key roles in helping their customers drive innovation and build solutions on Amazon Web Services (AWS). Amdocs has been named winner in two categories - Industry Partner of the Ye

      12/3/24 4:30:00 PM ET
      $DOX
      EDP Services
      Technology

    $DOX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Amdocs and Google Cloud Announce Partnership Expansion to Optimize 5G Network Operations with AI

      Amdocs will launch a solution using Google Cloud's AI and BigQuery to automate network operations and enhance customer experiences SUNNYVALE, Calif., Feb. 26, 2025 /PRNewswire/ -- Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, and Google Cloud today announced a major initiative to transform how telecommunications companies operate, maintain, and optimize critical 5G network ecosystems with AI. Using Google Cloud's Vertex AI and BigQuery, Amdocs will launch its new Network AIOps solution to help 5G network providers automate complex network operations, enhance service reliability, and improve customer experiences.

      2/26/25 4:00:00 PM ET
      $DOX
      EDP Services
      Technology
    • Amdocs Limited Files FY2024 Annual Report

      JERSEY CITY, NJ / ACCESSWIRE / December 17, 2024 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, has filed its Annual Report on Form 20-F for the fiscal year ended September 30, 2024 (including its financial statements for such year) with the U.S. Securities and Exchange Commission. The annual report is available through the Company's website (https://investors.amdocs.com/financial-information/sec-filings). Upon the request of a shareholder of the Company, the Company will promptly provide to such shareholder a copy of the 2024 annual report, free of charge.Supporting ResourcesKeep up with Amdocs news by visiting the company's website

      12/17/24 5:40:00 PM ET
      $DOX
      EDP Services
      Technology
    • Agentic Era Gives Birth to a New Branding Paradigm

      In the agentic era, service-intensive brands will need to consider the brand impact of the generative AI-based agents' personality on their customers in every interactionAmdocs global study reveals consumer preferences when interacting with AI agents and the key considerations brands must address during their journey into the agentic era JERSEY CITY, NJ / ACCESSWIRE / December 5, 2024 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today released a global study*, "Rethinking Brand and Customer Experience in the Agentic Era," commissioned by Amdocs in collaboration with McCann Tech agency and Coleman Parkes, which explores the impact o

      12/5/24 8:00:00 AM ET
      $DOX
      EDP Services
      Technology

    $DOX
    Financials

    Live finance-specific insights

    See more
    • Amdocs Limited Reports Fourth Quarter & Fiscal Year 2024 Results

      Record Fiscal 2024 Revenue of $5.00 Billion, up 2.4% YoY as Reported and 2.7% YoYin Constant Currency(1)Successfully Achieved Accelerated Profitability Improvement TargetsInitiates Fiscal 2025 Outlook:Sharpening Focus on Strategic Priorities while Phasing Out Certain Non-Core, Low Margin Business ActivitiesAs a Result of which Expects Fiscal 2025 Revenue Outlook of (10.9)%-(7.7)% YoY as Reported and 1%-4.5% YoY in Pro Forma(2) Constant Currency(1)Targeting Double-Digit Total Shareholder Returns(3)(4), Supported by Enhanced Profitability ImprovementBoard Approves 10% Increase of Quarterly Cash Dividend(4)Full Year Fiscal 2024 Highlights(All comparisons are against the prior year)Record revenu

      11/12/24 4:01:00 PM ET
      $DOX
      EDP Services
      Technology
    • Amdocs Limited Reports Third Quarter Fiscal 2024 Results

      Record Quarterly Revenue of $1.25 Billion, up 1.1% YoY as Reported and 1.8% YoY in Constant Currency(1)Record 12-Month Backlog of $4.25 Billion, up 2.7% YoYUpdates Fiscal 2024 Outlook:Expects Revenue Growth of 1.9%-2.7% YoY as ReportedReiterates Midpoint of Revenue Growth Outlook in Constant Currency(1) while Tightening Expected Range to 2.3%-3.1% YoYOn-track to Achieve Accelerated Profitability Targets in Fiscal 2024Expects GAAP Diluted EPS Growth of 7.4%-9.2% YoYReiterates Midpoint of Non-GAAP Diluted EPS Growth Outlook while Tightening Expected Range to 8.5%-9.5% YoYThird Quarter Fiscal 2024 Highlights(All comparisons are against the prior year)Record revenue of $1,250 million, up 1.1% as

      8/7/24 4:01:00 PM ET
      $DOX
      EDP Services
      Technology
    • Amdocs Limited Reports Second Quarter 2024 Results

      Record Quarterly Revenue of $1.25 Billion, up 1.8% YoY as Reported and 2% YoY in Constant Currency(1)Record 12-Month Backlog of $4.23 Billion, up ~3% YoYUpdates Fiscal 2024 Outlook:Expects Revenue Growth of 1.6%-3.6% YoY as Reported and 1.7%-3.7% YoY in Constant Currency(1)On-track to Deliver Accelerated Profitability in Fiscal 2024Expects GAAP Diluted EPS Growth of 7.0%-13.0% andNon-GAAP Diluted EPS Growth of 7.0%-11.0%Second Quarter Fiscal 2024 Highlights(All comparisons are against the prior year)Record revenue of $1,246 million, up 1.8% as reported and up 2.0% in constant currency(1); revenue was slightly above the midpoint of $1,225-$1,265 million guidance range and includes an unfavora

      5/8/24 4:10:00 PM ET
      $DOX
      EDP Services
      Technology